Company registration number 10037562 (England and Wales)
NEUROPSYCHOLOGY DIAGNOSTICS LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
NEUROPSYCHOLOGY DIAGNOSTICS LIMITED
COMPANY INFORMATION
Directors
Mr D P Friedland
Mrs J A Friedland
Dr N Friedland
(Appointed 1 March 2025)
Company number
10037562
Registered office
2nd Floor
Hygeia House
66 College Road
Harrow
Middlesex
United Kingdom
HA1 1BE
Accountants
Lawrence Grant LLP
2nd Floor
Hygeia House
66 College Road
Harrow
Middlesex
United Kingdom
HA1 1BE
NEUROPSYCHOLOGY DIAGNOSTICS LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 7
NEUROPSYCHOLOGY DIAGNOSTICS LIMITED
BALANCE SHEET
AS AT
31 MARCH 2025
31 March 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
-
0
-
0
Tangible assets
3
22,652
30,105
Investments
4
239,950
229,556
262,602
259,661
Current assets
Debtors
5
792,012
753,846
Cash at bank and in hand
1,881,989
1,291,396
2,674,001
2,045,242
Creditors: amounts falling due within one year
6
(436,174)
(309,945)
Net current assets
2,237,827
1,735,297
Total assets less current liabilities
2,500,429
1,994,958
Creditors: amounts falling due after more than one year
7
-
0
(18,079)
Provisions for liabilities
(5,663)
(7,526)
Net assets
2,494,766
1,969,353
Capital and reserves
Called up share capital
102
102
Other reserves
60,228
49,834
Profit and loss reserves
2,434,436
1,919,417
Total equity
2,494,766
1,969,353
NEUROPSYCHOLOGY DIAGNOSTICS LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 MARCH 2025
31 March 2025
- 2 -

For the financial year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 13 October 2025 and are signed on its behalf by:
Mr D P Friedland
Director
Company registration number 10037562 (England and Wales)
NEUROPSYCHOLOGY DIAGNOSTICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 3 -
1
Accounting policies
Company information

Neuropsychology Diagnostics Limited is a private company limited by shares incorporated in England and Wales. The registered office is 2nd Floor, Hygeia House, 66 College Road, Harrow, Middlesex, United Kingdom, HA1 1BE.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business, and is shown net of VAT and other sales related taxes.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that it is probable will be recover ed.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and machinery
25% reducing balance
Computers equipment
33% on cost
Motor vehicles
25% reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

NEUROPSYCHOLOGY DIAGNOSTICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 4 -

An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.

Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.

1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.6
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.7
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

NEUROPSYCHOLOGY DIAGNOSTICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 5 -
Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.8
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.9
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

1.10
Leases
As lessee

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

NEUROPSYCHOLOGY DIAGNOSTICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 6 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
2
2
3
Tangible fixed assets
Plant and machinery
Computers equipment
Motor vehicles
Total
£
£
£
£
Cost
At 1 April 2024
4,138
1,654
30,289
36,081
Additions
-
0
355
-
0
355
At 31 March 2025
4,138
2,009
30,289
36,436
Depreciation and impairment
At 1 April 2024
1,598
592
3,786
5,976
Depreciation charged in the year
636
546
6,626
7,808
At 31 March 2025
2,234
1,138
10,412
13,784
Carrying amount
At 31 March 2025
1,904
871
19,877
22,652
At 31 March 2024
2,540
1,062
26,503
30,105
4
Fixed asset investments
2025
2024
£
£
Other investments other than loans
239,950
229,556
NEUROPSYCHOLOGY DIAGNOSTICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
4
Fixed asset investments
(Continued)
- 7 -
Movements in fixed asset investments
Investments
£
Cost or valuation
At 1 April 2024
229,556
Valuation changes
10,394
At 31 March 2025
239,950
Carrying amount
At 31 March 2025
239,950
At 31 March 2024
229,556
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
639,737
531,130
Other debtors
152,275
222,716
792,012
753,846
6
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans and overdrafts
-
0
81
Taxation and social security
412,412
302,839
Other creditors
23,762
7,025
436,174
309,945
7
Creditors: amounts falling due after more than one year
2025
2024
£
£
Other creditors
-
0
18,079
8
Directors' transactions

During the year, total dividends of £186,800 (2024 - £1 30,400) were paid to the directors.

As at the year end date, the directors had a debit balance of £146,739 (2024 : £215,955) on their directors' current account. T his is included in other debtors.

2025-03-31 2024-04-01 false false false 13 October 2025 CCH Software CCH Accounts Production 2025.300 No description of principal activity Mr D P Friedland Mrs J A Friedland Dr N Friedland 10037562 2024-04-01 2025-03-31 10037562 bus:Director1 2024-04-01 2025-03-31 10037562 bus:Director2 2024-04-01 2025-03-31 10037562 bus:Director3 2024-04-01 2025-03-31 10037562 bus:RegisteredOffice 2024-04-01 2025-03-31 10037562 2025-03-31 10037562 2024-03-31 10037562 core:PlantMachinery 2025-03-31 10037562 core:ComputerEquipment 2025-03-31 10037562 core:MotorVehicles 2025-03-31 10037562 core:PlantMachinery 2024-03-31 10037562 core:ComputerEquipment 2024-03-31 10037562 core:MotorVehicles 2024-03-31 10037562 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 10037562 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 10037562 core:CurrentFinancialInstruments 2025-03-31 10037562 core:CurrentFinancialInstruments 2024-03-31 10037562 core:Non-currentFinancialInstruments 2025-03-31 10037562 core:Non-currentFinancialInstruments 2024-03-31 10037562 core:ShareCapital 2025-03-31 10037562 core:ShareCapital 2024-03-31 10037562 core:OtherMiscellaneousReserve 2025-03-31 10037562 core:OtherMiscellaneousReserve 2024-03-31 10037562 core:RetainedEarningsAccumulatedLosses 2025-03-31 10037562 core:RetainedEarningsAccumulatedLosses 2024-03-31 10037562 core:PlantMachinery 2024-04-01 2025-03-31 10037562 core:ComputerEquipment 2024-04-01 2025-03-31 10037562 core:MotorVehicles 2024-04-01 2025-03-31 10037562 2023-04-01 2024-03-31 10037562 core:PlantMachinery 2024-03-31 10037562 core:ComputerEquipment 2024-03-31 10037562 core:MotorVehicles 2024-03-31 10037562 2024-03-31 10037562 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 10037562 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 10037562 bus:FRS102 2024-04-01 2025-03-31 10037562 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 10037562 bus:FullAccounts 2024-04-01 2025-03-31 xbrli:pure xbrli:shares iso4217:GBP